Materials Displaying Neural Growth Factor Gradients and Applications in Neural Differentiation of Embryoid Body Cells
Source abstract
Abstract
The critical growth factor density required to support neural lineage generation from mouse embryonic stem cells is assessed by constructing a surface density gradient of immobilized nerve growth factor (NGF) from a plasma polymer film base. A chemical surface gradient varying from high hydroxyl group density to high aldehyde group density is prepared through diffusion‐controlled plasma polymerization of two monomers (ethanol and propionaldehyde) under a moving mask. NGF density gradients are then produced by reductive amination with the aldehyde groups on the plasma polymer surface. Mouse embryoid body derived (mEB) cell differentiation on the gradient surface is evaluated by immunofluorescence staining against Nestin. mEB cell density and the percentage of Nestin‐positive cells increase with increasing NGF density up to a critical value corresponding to 52.9 ng cm−2, above which cell attachment and differentiation do not increase further. This gradient‐based screening approach allows the growth factor surface densities to be optimized for biomaterials intended for cell differentiation or expansion, which is highly relevant to creating efficient manufacture processes for cell therapies.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nerve injury and regeneration · 3D Printing in Biomedical Research · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Mawson Institute University of South Australia Mawson Lakes SA 5095 Australia
Ian Wark Research Institute University of South Australia Mawson Lakes SA 5095 Australia
References (63)
Show source-provided references
1. 10.1016/j.biomaterials.2006.07.04310.1016/j.biomaterials.2006.07.043 ↗
2. 10.1126/science.117164310.1126/science.1171643 ↗
3. 10.1002/jbm.b.3084110.1002/jbm.b.30841 ↗
4. 10.1016/j.biomaterials.2013.06.02210.1016/j.biomaterials.2013.06.022 ↗
5. 10.1016/j.diff.2013.06.00610.1016/j.diff.2013.06.006 ↗
6. 10.1016/j.biomaterials.2006.10.00410.1016/j.biomaterials.2006.10.004 ↗
7. 10.1002/polb.2327510.1002/polb.23275 ↗
8. Lutolf M. P. · Nature · 462 · 43310.1038/nature08602 ↗
9. Venero J. L. · Mol. Pharmacol. · 1996 · 49 · 30310.1016/S0026-895X(25)08712-7 ↗
10. 10.1007/978-1-4615-3088-6_1010.1007/978-1-4615-3088-6_10 ↗
11. Giri D. · Clin. Cancer Res. · 1999 · 5 · 1063
12. 10.1111/j.1470-8744.1992.tb00220.x10.1111/j.1470-8744.1992.tb00220.x ↗
13. 10.1042/BA2000006110.1042/BA20000061 ↗
14. 10.1201/b1458410.1201/b14584 ↗
15. 10.1016/j.bbrc.2011.03.00510.1016/j.bbrc.2011.03.005 ↗
16. 10.1182/blood.V85.3.641.bloodjournal85364110.1182/blood.V85.3.641.bloodjournal853641 ↗
17. 10.1042/BA2005007510.1042/BA20050075 ↗
18. 10.1016/j.biomaterials.2009.04.04310.1016/j.biomaterials.2009.04.043 ↗
19. 10.1016/j.apsusc.2008.02.11810.1016/j.apsusc.2008.02.118 ↗
20. 10.1016/j.biomaterials.2013.05.08010.1016/j.biomaterials.2013.05.080 ↗
21. 10.1166/sl.2009.118010.1166/sl.2009.1180 ↗
22. 10.1016/j.actbio.2012.01.03410.1016/j.actbio.2012.01.034 ↗
23. 10.1016/j.biomaterials.2009.09.05610.1016/j.biomaterials.2009.09.056 ↗
24. Harding F. · Adv. Healthcare Mater. · 2012 · 8 · 1739
25. 10.1039/b904367e10.1039/b904367e ↗
26. 10.1002/ppap.20100003010.1002/ppap.201000030 ↗
27. 10.1021/am300128n10.1021/am300128n ↗
28. 10.1021/la204714p10.1021/la204714p ↗
29. 10.1002/jbm.a.1035610.1002/jbm.a.10356 ↗
30. 10.1155/2012/83905310.1155/2012/839053 ↗
31. 10.1016/j.biomaterials.2007.09.02610.1016/j.biomaterials.2007.09.026 ↗
32. 10.1146/annurev-matsci-070511-15505010.1146/annurev-matsci-070511-155050 ↗
33. 10.1016/j.biomaterials.2010.05.07010.1016/j.biomaterials.2010.05.070 ↗
34. Bartkowska K. · Acta Neurobiol. Exp. · 2010 · 70 · 45410.55782/ane-2010-1816 ↗
35. Hung C.‐H. · BME · 2013 · 25 · 1
36. 10.1007/s12035-012-8357-710.1007/s12035-012-8357-7 ↗
37. 10.1016/j.neuroscience.2012.02.03410.1016/j.neuroscience.2012.02.034 ↗
38. 10.1007/s10072-011-0512-910.1007/s10072-011-0512-9 ↗
39. 10.3389/fncel.2012.0006110.3389/fncel.2012.00061 ↗
40. 10.1016/S0079-6123(08)60993-010.1016/S0079-6123(08)60993-0 ↗
41. 10.1146/annurev.neuro.24.1.60110.1146/annurev.neuro.24.1.601 ↗
42. 10.1111/j.1527-3458.2005.tb00037.x10.1111/j.1527-3458.2005.tb00037.x ↗
43. 10.1002/jbm.a.3081310.1002/jbm.a.30813 ↗
44. 10.1098/rsif.2008.040310.1098/rsif.2008.0403 ↗
45. c)C.Chun J. J.Hickman W.Wang C.Gregory S.Narayanan M.Poeta presented at Conf. 24th Army Sci. Orlando November2004;
46. 10.1088/0957-4484/20/27/27510210.1088/0957-4484/20/27/275102 ↗
47. 10.1002/jbm.a.3469310.1002/jbm.a.34693 ↗
48. 10.1002/jbm.a.1016810.1002/jbm.a.10168 ↗
49. Park S. C. · TERM · 2011 · 8 · 192
50. 10.1002/jbm.a.3104710.1002/jbm.a.31047 ↗
51. 10.1163/15685620577426948510.1163/156856205774269485 ↗
52. 10.1089/ten.2006.12.26710.1089/ten.2006.12.267 ↗
53. 10.1385/MN:27:3:27710.1385/MN:27:3:277 ↗
54. 10.1016/j.neulet.2011.06.02310.1016/j.neulet.2011.06.023 ↗
55. 10.1016/j.cbpa.2006.09.00910.1016/j.cbpa.2006.09.009 ↗
56. 10.1016/j.biomaterials.2005.06.03010.1016/j.biomaterials.2005.06.030 ↗
57. Intranuovo F. · Bone · 2008 · 15 · 16
58. 10.1002/ppap.20060002110.1002/ppap.200600021 ↗
59. 10.1021/la060276610.1021/la0602766 ↗
60. 10.1016/j.actbio.2011.09.00110.1016/j.actbio.2011.09.001 ↗
61. 10.1002/stem.54110.1002/stem.541 ↗
62. 10.1126/science.106491310.1126/science.1064913 ↗
63. 10.1039/b305445b10.1039/b305445b ↗